Navigation Links
Amarin Commences First Clinical Trial in Cardiovascular ProgramAmarin Commences First Clinical Trial in Cardiovascular Program
Date:11/29/2007

Initiates Phase I Clinical Trial to Evaluate Ultra-Pure Ethyl EPA-Niacin

for Treatment of Niacin- Induced Flushing

LONDON, November 29 /PRNewswire-FirstCall/ -- Amarin Corporation plc (NASDAQ: AMRN) today announced that it has commenced a phase I clinical safety and efficacy trial in volunteers. The trial will evaluate the co-administration of ultra-pure ethyl EPA and niacin on niacin induced flushing. Flushing is a common side effect of niacin treatment which significantly limits patient compliance.

Niacin is a treatment is used to increase High Density Lipoprotein (HDL) and modestly decrease triglyceride levels in dyslipidemia or cholesterol management. Ultra-pure ethyl EPA has been prescribed in Japan for over 15 years for the treatment of triglyceride lowering. Ultra-pure ethyl EPA is known to have several additional beneficial effects in cardiovascular disease.

Rick Stewart, Chief Executive Officer commented, "The initiation of this study is significant because it marks the commencement of Amarin's cardiovascular development program and potentially addresses a major medical need. Niacin is a valuable addition to the treatment of dyslipidemia but its principal drawback is flushing."

Mr. Stewart continued, "Amarin's cardiovascular program capitalizes on the known therapeutic benefits of ultra-pure EPA in cardiovascular disease and is a logical extension from Amarin's existing therapeutic base for ultra-pure EPA and its derivatives. By using ultra-pure EPA and niacin together, both HDL and triglycerides can be managed. We believe this combination can be a useful therapeutic proposition. We are fortunate to have the know-how, the intellectual property, the resources and th
'/>"/>

SOURCE Amarin Corporation Plc
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntingtons Disease Program
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Exelixis Commences Public Offering of Common Stock
4. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
5. American Physicians Capital, Inc. Completes $15 Million Authorization and Commences $20 Million Authorization Under Stock Repurchase Program
6. First biomarker discovered that predicts prostate cancer outcome
7. FDA Approves First Anti-Psychotic for Kids
8. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
9. First study examines newly-licensed RN work attitudes and intentions
10. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
11. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Better Life Maids of Portland Oregon is putting on ... one of a kind green house cleaning service in the ... May 29th, and a soft opening scheduled for June 3rd, ... in Portland recently and will travel to St. Louis June ... really is a lot to take in" stated Heather Richardson. ...
(Date:5/23/2013)... 23, 2013 Footwear etc. is pleased to ... Collection of sandals containing cork footbeds. Known for its extremely ... good sales for many years, and with this new collection ... , Dansko Shoes and Sandals are renowned ... is no exception. Containing leather and patent leather uppers in ...
(Date:5/23/2013)... Long-Term Care Insurance shopping site LTC Tree has ... for Long Term Care Insurance are approved by insurance companies ... to buy a Long Term Care Insurance policy is an ... purchase protection are increasingly being turned away by insurance companies, ... variety of chronic conditions appear to be responsible for the ...
(Date:5/23/2013)... AttorneyOne.com, a recognized authority on law, ... providing expert opinion in view of the recent news ... to court documents, on March 5, 2013 a woman ... no. 3:2013cv50102) alleging that her husband suffered massive brain ... is mainly used as a blood thinner for patients ...
(Date:5/22/2013)... St. Petersburg, FL (PRWEB) May 23, 2013 ... rarely affects men due to several factors, including estrogen ... Cellulite is essentially toxins and fatty deposits stored and ... skin. "To diminish cellulite, one must take a multi-pronged ... These multi-pronged actions include: , Specific products like ...
Breaking Medicine News(10 mins):Health News:Better Life Maids of Portland Oregon Prepares For a Summer of 2013 Launch 2Health News:Footwear etc. Announces the New Collection of Dansko Cork Sandals 2Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 2Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 3Health News:New Lawsuit on Pradaxa Brain Hemorrhage: Now, AttorneyOne Can Provide Advice 2Health News:Get Cellulite Under Control Now with Cellulite Whisperer® Products Introduced by Sublime Beauty® 2
... H1N1 in a cat or pigs are likely very rare, experts ... news broke on Wednesday that a domestic cat had come down ... owners, many people no doubt wondered how vulnerable their own pets ... protecting from this strain of flu? The answer, experts say, is ...
... EF Johnson Technologies, Inc. (Nasdaq: EFJI ) ... results for the quarter ending September 30, 2009, and ... 4:30 p.m. Eastern Time on Thursday, November 12, 2009. ... Jana Ahlfinger Bell, executive vice president and chief financial ...
... , PURCHASE, N.Y., Nov. 4 Nutrition 21, Inc. ... ingredients and finished products under the Iceland Health®, Chromax®, ... sugar levels, improve cardiovascular health, enhance memory and reduce ... first quarter of fiscal year 2010 ended September 30, ...
... differently than Gardasil, Cervarix, it targets inside of virus, ... A vaccine that targets human papillomavirus (HPV) is able ... into full-blown malignancies, Dutch researchers report. , Two other ... for young women to prevent infection with HPV, which ...
... Inc. (Nasdaq: GHDX ) today reported financial results and business ... increased to $39.5 million in the third quarter of 2009 compared ... revenue from the Onco type DX® breast cancer test was ... 39 percent, compared with $28.1 million in the third quarter of ...
... Nov. 4 (HealthDay News) -- Eating too fast can lead ... hormones in the gut that trigger the feeling of being ... ate 300 milliliters of ice cream at different rates. Blood ... before and after consumption of the ice cream. Participants who ...
Cached Medicine News:Health News:Rest Easy. When It Comes to Swine Flu, Your Pet Is Safe 2Health News:Rest Easy. When It Comes to Swine Flu, Your Pet Is Safe 3Health News:EF Johnson Technologies, Inc. Announces Third Quarter Financial Reporting Date 2Health News:Nutrition 21 Announces Fiscal First Quarter 2010 Financial Results 2Health News:Nutrition 21 Announces Fiscal First Quarter 2010 Financial Results 3Health News:Nutrition 21 Announces Fiscal First Quarter 2010 Financial Results 4Health News:Nutrition 21 Announces Fiscal First Quarter 2010 Financial Results 5Health News:Nutrition 21 Announces Fiscal First Quarter 2010 Financial Results 6Health News:New HPV Vaccine Might Stop Vulvar Cancer in its Tracks 2Health News:New HPV Vaccine Might Stop Vulvar Cancer in its Tracks 3Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 2Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 3Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 4Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 5Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 6Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 7Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 8Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 9Health News:Fast Eating Limits Gut Hormones That Induce Fullness 2
(Date:5/23/2013)... 22. Mai 2013 Ranbaxy ... Tochtergesellschaft von Daiichi Sankyo Co., Ltd. ... 22. Mai die Maßnahmen bekannt, die ... hat, um sich der Angelegenheiten der ... http://www.daiichisankyo.com/media_investors/media_relations/press_releases/index.html ). Daiichi Sankyo ...
(Date:5/22/2013)... May 22, 2013  Heska Corporation (NASDAQ: HSKA, "Heska" or ... products, announced today that the Company will present at the ... 2013 at the Le Parker Meridian hotel, 119 W. 56 ... . The presentation is scheduled to begin at 2:15 p.m. ... Heska Heska Corporation (NASDAQ: HSKA - ...
(Date:5/22/2013)... May 22, 2013  Team Health Holdings Inc. ("TeamHealth") ... suppliers of outsourced healthcare professional staffing and administrative services ... the United States , today announced that its ... Bank Healthcare Conference held on May 29, 2013 at ... 8:00 AM eastern time.  Interested investors and other parties ...
Breaking Medicine Technology:Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an 2Team Health Holdings Inc. to Present at the 38th Annual Deutsche Bank Healthcare Conference 2
... THE WOODLANDS, Texas , Jan. 25 In response ... York Times article, " Radiation Offers New Cures and Ways to ... patients and the general public understand that the benefits received from radiation therapy ... disease with help from the US Oncology physician network, and their loved ones, ...
... , , , MOUNTAIN VIEW, Calif. ... enrollment of its pivotal US study for the ArterX Vascular ... patients who were scheduled to receive a synthetic vascular graft ... applications involved the placement of arteriovenous dialysis access grafts, carotid ...
Cached Medicine Technology:Benefits from Radiation Therapy Outweigh Risks for Cancer Patients 2Benefits from Radiation Therapy Outweigh Risks for Cancer Patients 3Tenaxis Medical, Inc. Announces Completion of the Enrollment Phase of Their Pivotal Study 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: